I’ve been back in Nashville, TN since mid November writing and re-connecting with some folks and, most importantly, working on a new record with Grammy winning producer and engineer, Richie Biggs. We’ve been spending some time at the coziest studio I’ve ever worked in (Art House Studios), just south of Nashville, and have been getting some great sounds! Richie has selected a killer group of players and is adeptly navigating the musical the ship into waters that I, quite honestly, never thought we’d see. The production is anything but predictable and is feeling really, really good. Frankly, this project is going to be totally unlike anything I have ever done to date, and I couldn’t be happier to explore some new creative territory! Having a great team and a terrific captain in charge has taken the load off in many ways and really has enabled me to relax, work on my performances, and just enjoy the process. Now, if I could only get some sleep…
My Taylor Guitars 814ce’s and Deering Banjo Co. Boston 6-String in action at Art House Studios in Nashville, TN.
Life in the van has been little crazy with all the running around, writing, rehearsing, and working, but having a dependable base camp at my buddy’s (and frequent co-writer) driveway has been an absolute blessing. It’s always nice to know where I’ll be ending up at the end of a long day and having a friendly, safe spot to hang is so tremendously appreciated on many a rainy night so far this winter in the Southeast. All in all, it’s been a killer couple of weeks back here with a mini break to visit some family for Thanksgiving, and I am truly excited to see where the next couple of sessions take us in the studio. Thus far, we’ve tracked a total of eight (8) songs with the band, and we have a budget for maybe a few more, with an acoustic / performance-style track or two in the cards. This week is all wrapped, but we’ll be getting back to it for a few more sessions before the holidays, so stay tuned on Facebook, Instagram, and Twitter for frequent updates on the project, timelines, and more. In the mean time, it’s back to the van to cook up some more ideas to see if I might just beat anything we’ve left to record, writing-wise. Here we go!
Experimenting with some different sounds in the van in between recording sessions at Art House Studios.
Big thanks to my friends at Taylor Guitars, Deering Banjo Co., and Elixir Strings for their on-going support of my music career, as well as all the friends and family (both new and old) who’ve provided a friendly van spot over the last year of gigs, radio interviews, writing appointments, etc. on the road. Thanks, too, to each and every one of the venues who’ve been kind enough to host my performances and, in turn, help finance this new project. I really couldn’t do it without you guys! So, stay tuned and, in the mean time, best wishes for a wonderful holiday season to all!
This entry was posted on Friday, December 2nd, 2016 at 4:17 PM. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
1. ASPEN Board of Directors and the Clinical Guidelines Task Force. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr. 2002;26(1 Suppl):1SA–138SA.[PubMed]
2. Maroulis J, Kalfarentzos F. Complications of parenteral nutrition at the end of the century. Clin Nutr. 2000;19:295–304. doi: 10.1054/clnu.1999.0089. Available from: http://dx.doi.org/10.1054/clnu.1999.0089. [PubMed][Cross Ref]
3. Koretz RL, Lipman TO, Klein S American Gastroenterological Association. AGA technical review on parenteral nutrition. Gastroenterology. 2001;121(4):970–1001. doi: 10.1016/S0016-5085(01)92000-1. Available from: http://dx.doi.org/10.1016/S0016-5085(01)92000-1. [PubMed][Cross Ref]
4. Braunschweig CL, Levy P, Sheean PM, Wang X. Enteral compared with parenteral nutrition: a meta-analysis. Am J Clin Nutr. 2001;74(4):534–542.[PubMed]
5. Van den Berghe G. Insulin therapy for the critically ill patient. Clin Cornerstone. 2003;5(2):56–63. doi: 10.1016/S1098-3597(03)90018-4. Available from: http://dx.doi.org/10.1016/S1098-3597(03)90018-4. [PubMed][Cross Ref]
6. Marik PE, Pinsky M. Death by parenteral nutrition. Intensive Care Med. 2003;29(6):867–869. doi: 10.1007/s00134-003-1995-5. Available from: http://dx.doi.org/10.1007/s00134-003-1995-5. [PubMed][Cross Ref]
7. Anderson AD, Jain PK, MacFie J. Parenteral nutrition in the critically ill. Intensive Care Med. 2003;29(11):2103. doi: 10.1007/s00134-003-1996-4. Available from: http://dx.doi.org/10.1007/s00134-003-1996-4. [PubMed][Cross Ref]
8. Fürst P. Comment on "Death by parenteral nutrition" by Marik and Pinsky. Intensive Care Med. 2003;29(11):2102. doi: 10.1007/s00134-003-2023-5. Available from: http://dx.doi.org/10.1007/s00134-003-2023-5. [PubMed][Cross Ref]
9. Varga P, Griffiths R, Chiolero R, Nitenberg G, Leverve X, Pertkiewicz M, Roth E, Wernerman J, Pichard C, Preiser JC. Is parenteral nutrition guilty? Intensive Care Med. 2003;29(11):1861–1864. doi: 10.1007/s00134-003-2006-6. Available from: http://dx.doi.org/10.1007/s00134-003-2006-6. [PubMed][Cross Ref]
10. Alpers DH. Enteral feeding and gut atrophy. Curr Opin Clin Nutr Metab Care. 2002;5(6):679–683. doi: 10.1097/00075197-200211000-00011. Available from: http://dx.doi.org/10.1097/00075197-200211000-00011. [PubMed][Cross Ref]
11. Bistrian BR. Update on total parenteral nutrition. Am J Clin Nutr. 2001;74(2):153–154.[PubMed]
12. Jeejeebhoy KN. Total parenteral nutrition: potion or poison? Am J Clin Nutr. 2001;74(2):160–163.[PubMed]
13. Richards DM, Deeks JJ, Sheldon TA, Shaffer JL. Home parenteral nutrition: a systematic review. Health Technol Assess. 1997;1(1):i–iii, 1.[PubMed]
14. Klein S. A primer of nutritional support for gastroenterologists. Gastroenterology. 2002;122(6):1677–1687. doi: 10.1053/gast.2002.33574. Available from: http://dx.doi.org/10.1053/gast.2002.33574. [PubMed][Cross Ref]
15. Buchman AL, Moukarzel AA, Bhuta S, Belle M, Ament ME, Eckhert CD, Hollander D, Gornbein J, Kopple JD, Vijayaroghavan SR. Parenteral nutrition is associated with intestinal morphologic and functional changes in humans. JPEN J Parenter Enteral Nutr. 1995;19(6):453–460. doi: 10.1177/0148607195019006453. Available from: http://dx.doi.org/10.1177/0148607195019006453. [PubMed][Cross Ref]
16. Guedon C, Schmitz J, Lerebours E, Metayer J, Audran E, Hemet J, Colin R. Decreased brush border hydrolase activities without gross morphologic changes in human intestinal mucosa after prolonged total parenteral nutrition of adults. Gastroenterology. 1986;90(2):373–378.[PubMed]
17. Pironi L, Paganelli GM, Miglioli M, Biasco G, Santucci R, Ruggeri E, Di Febo G, Barbara L. Morphologic and cytoproliferative patterns of duodenal mucosa in two patients after long-term total parenteral nutrition: changes with oral refeeding and relation to intestinal resection. JPEN J Parenter Enteral Nutr. 1994;18(4):351–354. doi: 10.1177/0148607194018004351. Available from: http://dx.doi.org/10.1177/0148607194018004351. [PubMed][Cross Ref]
18. Sedman PC, MacFie J, Palmer MD, Mitchell CJ, Sagar PM. Preoperative total parenteral nutrition is not associated with mucosal atrophy or bacterial translocation in humans. Br J Surg. 1995;82(12):1663–1667. doi: 10.1002/bjs.1800821226. Available from: http://dx.doi.org/10.1002/bjs.1800821226. [PubMed][Cross Ref]
19. van der Hulst RR, van Kreel BK, von Meyenfeldt MF, Brummer RJ, Arends JW, Deutz NE, Soeters PB. Glutamine and the preservation of gut integrity. Lancet. 1993;341(8857):1363–1365. doi: 10.1016/0140-6736(93)90939-E. Available from: http://dx.doi.org/10.1016/0140-6736(93)90939-E. [PubMed][Cross Ref]
20. van der Hulst RR, von Meyenfeldt MF, Tiebosch A, Buurman WA, Soeters PB. Glutamine and intestinal immune cells in humans. JPEN J Parenter Enteral Nutr. 1997;21(6):310–315. doi: 10.1177/0148607197021006310. Available from: http://dx.doi.org/10.1177/0148607197021006310. [PubMed][Cross Ref]
21. van der Hulst RR, von Meyenfeldt MF, Deutz NE, Stockbrügger RW, Soeters PB. The effect of glutamine administration on intestinal glutamine content. J Surg Res. 1996;61(1):30–34. doi: 10.1006/jsre.1996.0076. Available from: http://dx.doi.org/10.1006/jsre.1996.0076. [PubMed][Cross Ref]
22. Ahlman B, Ljungqvist O, Persson B, Bindslev L, Wernerman J. Intestinal amino acid content in critically ill patients. JPEN J Parenter Enteral Nutr. 1995;19(4):272–278. doi: 10.1177/0148607195019004272. Available from: http://dx.doi.org/10.1177/0148607195019004272. [PubMed][Cross Ref]
23. Hadfield RJ, Sinclair DG, Houldsworth PE, Evans TW. Effects of enteral and parenteral nutrition on gut mucosal permeability in the critically ill. Am J Respir Crit Care Med. 1995;152(5 Pt 1):1545–1548.[PubMed]
24. Safe Practices for Parenteral Nutrition Formulations. National Advisory Group on Standards and Practice Guidelines for Parenteral Nutrition. JPEN J Parenter Enteral Nutr. 1998;22(2):49–66. doi: 10.1177/014860719802200249. Available from: http://dx.doi.org/10.1177/014860719802200249. [PubMed][Cross Ref]
25. Llop J, Sabin P, Garau M, Burgos R, Pérez M, Massó J, Cardona D, Sánchez Segura JM, Garriga R, Redondo S, Sagalés M, Ferrer D, Pons M, Vuelta M, Fàbregas X, Vitales M, Casasín T, Martínez J, Morató L, Soler M Hospital Pharmacy Artificial Nutrition Group of Catalonia. The importance of clinical factors in parenteral nutrition-associated hypertriglyceridemia. Clin Nutr. 2003;22(6):577–583. doi: 10.1016/S0261-5614(03)00082-7. Available from: http://dx.doi.org/10.1016/S0261-5614(03)00082-7. [PubMed][Cross Ref]
26. Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA. 2003;290(15):2041–2047. doi: 10.1001/jama.290.15.2041. Available from: http://dx.doi.org/10.1001/jama.290.15.2041. [PubMed][Cross Ref]
27. Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ. 1997;314(7093):1512–1515.[PMC free article][PubMed]
28. Meier JJ, Deifuss S, Gallwitz B, Klamann A, Schmiegel W, Nauck MA. Einfluss einer eingeschränkten Glukosetoleranz auf das Langzeitüberleben nach akutem Myokardinfarkt The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA) [Influence of impaired glucose tolerance on long-term survival after acute myocardial infarction]. Dtsch Med Wochenschr. 2002;127(21):1123–1129. doi: 10.1055/s-2002-31529. (Ger). Available from: http://dx.doi.org/10.1055/s-2002-31529. [PubMed][Cross Ref]
29. Norhammar AM, Rydén L, Malmberg K. Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care. 1999;22(11):1827–1831. doi: 10.2337/diacare.22.11.1827. Available from: http://dx.doi.org/10.2337/diacare.22.11.1827. [PubMed][Cross Ref]
30. Parsons MW, Barber PA, Desmond PM, Baird TA, Darby DG, Byrnes G, Tress BM, Davis SM. Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol. 2002;52(1):20–28. doi: 10.1002/ana.10241. Available from: http://dx.doi.org/10.1002/ana.10241. [PubMed][Cross Ref]
31. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87(3):978–982. doi: 10.1210/jc.87.3.978. Available from: http://dx.doi.org/10.1210/jc.87.3.978. [PubMed][Cross Ref]
32. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345(19):1359–1367. doi: 10.1056/NEJMoa011300. Available from: http://dx.doi.org/10.1056/NEJMoa011300. [PubMed][Cross Ref]
33. Weir CJ, Murray GD, Dyker AG, Lees KR. Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study. BMJ. 1997;314(7090):1303–1306.[PMC free article][PubMed]
34. Zindrou D, Taylor KM, Bagger JP. Admission plasma glucose: an independent risk factor in nondiabetic women after coronary artery bypass grafting. Diabetes Care. 2001;24(9):1634–1639. doi: 10.2337/diacare.24.9.1634.